Publications by authors named "Svasti Haricharan"

15Publications

Endocrine therapy resistance: new insights.

Breast 2019 Nov;48 Suppl 1:S26-S30

Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA; Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA; Interdepartmental Graduate Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0960-9776(19)31118-XDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939855PMC
November 2019

CDK4/6 Inhibitor Biomarker Research: Are We Barking Up the Wrong Tree?

Clin Cancer Res 2020 01 5;26(1):3-5. Epub 2019 Nov 5.

Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-19-3119DOI Listing
January 2020

DNA damage repair defects as a new class of endocrine treatment resistance driver.

Oncotarget 2018 Nov 20;9(91):36252-36253. Epub 2018 Nov 20.

Svasti Haricharan: Department of Tumor Microenvironment and Cancer Immunology, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.26363DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284739PMC
November 2018

Defects in mismatch repair: the Achilles heel of estrogen receptor positive breast cancer with intrinsic endocrine therapy resistance?

Oncoscience 2017 Jul 21;4(7-8):77-78. Epub 2017 Sep 21.

Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncoscience.363DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616200PMC
July 2017

Mammary Ductal Environment Is Necessary for Faithful Maintenance of Estrogen Signaling in ER⁺ Breast Cancer.

Cancer Cell 2016 Mar;29(3):249-250

Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA; Interdepartmental Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047062PMC
http://dx.doi.org/10.1016/j.ccell.2016.02.017DOI Listing
March 2016

TLR4 has a TP53-dependent dual role in regulating breast cancer cell growth.

Proc Natl Acad Sci U S A 2015 Jun 10;112(25):E3216-25. Epub 2015 Jun 10.

Department of Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1420811112DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485113PMC
June 2015

Somatic mutation load of estrogen receptor-positive breast tumors predicts overall survival: an analysis of genome sequence data.

Breast Cancer Res Treat 2014 Jul 18;146(1):211-20. Epub 2014 May 18.

Department of Clinical Cancer Prevention, Unit 1360, The University of Texas M.D. Anderson Cancer Center, P.O. Box 301439, Houston, TX, 77030-1439, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-014-2991-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061465PMC
July 2014

Ku must load directly onto the chromosome end in order to mediate its telomeric functions.

PLoS Genet 2011 Aug 11;7(8):e1002233. Epub 2011 Aug 11.

Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States of America.

View Article

Download full-text PDF

Source
http://dx.plos.org/10.1371/journal.pgen.1002233
Publisher Site
http://dx.doi.org/10.1371/journal.pgen.1002233DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154960PMC
August 2011